| Capricorn Pharma Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100196466 | DRUG DELIVERY SYSTEM - A novel encapsulated product is provided and includes: at least one pharmaceutical; at least one compressible material; and at least one tableting material; wherein the encapsulated product is in the form of a caplet having a diameter of from about 1 millimeter to about 7 millimeters and a length from about 1 millimeter to about 7 millimeters. A method for preparing the encapsulated product is also provided. | 08-05-2010 |
| 20100010101 | Rapid-Melt Compositions and Methods of Making Same - The present invention provides a novel rapid-melt pharmaceutical composition comprising a binder, a super emulsifier, a diluent/bulking material; and an active ingredient. The present invention also provides a rapid-melt bead composition comprising a binder having a melting point from about 20 to about 90° C., an emulsifier; a diluent/bulking material; and an active ingredient. Further, the present invention provides a chew tablet composition comprising a binder; an emulsifier having a melting point of greater than about 40° C.; a diluent/bulking material; and an active ingredient. Methods of making the disclosed compositions are also described. | 01-14-2010 |
| 20090311317 | MODIFIED RELEASE TOLTERODINE FORMULATIONS - Modified or extended release formulations containing tolterodine and associated methods are disclosed and described. Methods for making and administering said modified release formulations are also disclosed. | 12-17-2009 |
| 20090304824 | Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same - A novel rapid-melt composition, including methods of making the same, and methods of using the same for the delivery of prophylactic and therapeutic active materials to a mammal. The rapid-melt compositions are formed by molding or compression, with an additional heating step being preferred. | 12-10-2009 |
| 20090136550 | MODIFIED RELEASE FORMULATIONS OF DILTIAZEM - Modified release diltiazem compositions and associated methods of preparation and administration are provided. | 05-28-2009 |
| 20090130208 | Modified release niacin formulations - Modified release niacin formulations, methods for making the formulations, and methods of using the formulations. | 05-21-2009 |
| 20090017110 | MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABILITY DRUGS - Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved mesalamine formulations such as PENTASA®. | 01-15-2009 |
